DelveInsight launched a new report on Hepatitis D Virus Infection Pipeline Insights 2020.

 

Hepatitis D Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Hepatitis D market. A detailed picture of the Hepatitis D pipeline landscape is provided, which includes the disease overview and Hepatitis D treatment guidelines. 

 

 

HDV is a viral infection that causes liver inflammation, sometimes leading to serious liver damage. It is caused by the hepatitis D virus (HDV) and is considered to be the most severe form of viral hepatitis in humans due to more rapid progression toward liver-related death and hepatocellular carcinoma. HDV requires hepatitis B virus (HBV) for its replication. HDV infection occurs as co-infection or as super-infection with HBV.

 

 

 

 

These cases are expected to grow with a significant CAGR in the study period 2017–2030.

Emerging Therapies:

1. Hepcludex/Bulevirtide

2. Lonafarnib

3. JNJ-3989

Key pharma players involved:

1. Hepcludex/Bulevirtide

2. Eiger Biopharmaceuticals

3. Janssen Pharmaceuticals

Click here and download free sample pages of the report.

Table of contents:

1. Report Introduction

2. Hepatitis D 

3. Hepatitis D Current Treatment Patterns

4. Hepatitis D – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Hepatitis D Late Stage Products (Phase-III)

7. Hepatitis D Mid Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Hepatitis D Discontinued Products

13. Hepatitis D Product Profiles

14. Hepatitis D Key Companies

15. Hepatitis D Key Products

16. Dormant and Discontinued Products

17. Hepatitis D Unmet Needs

18. Hepatitis D Future Perspectives

19. Hepatitis D Analyst Review  

20. Appendix

21. Report Methodology

Download our full report: https://www.delveinsight.com/report-store/hepatitis-d-pipeline-insight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.